Sign in
4

Changes in Ownership

Avalo Therapeutics, Inc. Filed Acc 0001247024-26-000002

Director acquired 3,166 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
KAPLAN GILLA Director 2026-03-28 Option exercise +3,166 6,333 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
KAPLAN GILLA Director 2026-03-28 Option exercise · Restricted Stock Units −3,166 3,167 D: show line 2 in the form
Loading xslF345X06/form4-03312026_080359.xml…